Skip to content
Aakaar Medical Technologies logo

Aakaar Medical Technologies

AAKAAR NSE
₹69.95 up 3.20 (4.79%)
Market Cap
₹99.14 Cr

Aakaar Medical Technologies (AAKAAR) share price was ₹69.95 at the 28 Oct 2026 close; market capitalisation ₹99.14 Cr; sector Consumer Goods. The share price fell 16.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 22.9% year on year to ₹41.64 Cr and net profit rose 33.2% year on year to ₹7.42 Cr (compared with Mar 2025). Promoters held 67.05% of Aakaar Medical Technologies in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 62/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹69.95 −16.05 −18.66% 1Y

Key Fundamentals

SMEPersonal ProductsFMCG
Market Cap
₹99.14 Cr
EBITDA
₹11.10 Cr
Return on Equity
12.17%
Return on Capital Employed
19.79%
Debt to Equity
0.34
Book Value
₹38.49
EPS (TTM)
—
52W High
₹89.95
52W Low
₹46.00

Price-based figures as of 28 Oct 2026, 11:23 IST · TTM

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Personal Care

Godrej Consumer Products
₹826.1544.1684,540 Cr6.691.21%14.71%21.44%16,116 Cr1,914 Cr
Dabur India
₹367.7033.0765,228 Cr5.712.31%15.83%20.96%14,181 Cr1,947 Cr
Colgate Palmolive
₹1,616.7032.2943,972 Cr27.181.50%83.66%107.36%6,491 Cr1,362 Cr
Cupid
₹325.75319.3643,802 Cr97.241.58%24.01%30.87%484 Cr137 Cr
Gillette
₹7,194.0035.0923,442 Cr24.773.28%69.13%84.58%3,202 Cr668 Cr
P&G Hygiene and Health Care
₹6,877.0028.2322,323 Cr29.633.77%113.67%135.44%4,289 Cr790 Cr
Emami
₹372.3021.7116,251 Cr5.562.71%26.53%28.59%3,997 Cr749 Cr
Aakaar Medical Technologies (this company)
₹69.95—99 Cr1.820.00%12.17%19.79%——
Median 8 companies₹599.2333.0733,622 Cr15.731.95%25.27%29.73%4,289 Cr790 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

62 Good
Overall score

Data confidence 84/100

Category scores

Quality Strong 69
Returns, margins, earnings quality 22% weight
Valuation Weak 37
Cheap vs sector & own history 24% weight
Growth Average 50
Sales & profit trajectory 9% weight
Financial Health Strong 71
Solvency, leverage, coverage 9% weight
Momentum Strong 89
Trend strength, vol-adjusted 12% weight
Ownership Strong 67
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has delivered good profit growth of 65.2% CAGR over last 5 years

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 203 days.
  • Working capital days have increased from 130 days to 199 days

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bullish

Bearish
2
Neutral
6
Bullish
11

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
9.71% lower than 3Y

change over 1 year

Net Income Growth
10% lower than 3Y

change over 1 year

Cash Flow Change
-54.53%

change over 1 year

EBITDA Margin Change
1.8%

change over 1 year Operating margin 25.02% · Mar 2026

Quarterly Results

Particulars Mar 2025Sep 2025Mar 2026
Sales
33.88
25.32
41.64
Expenses
25.53
25.55
31.22
Operating Profit
8.35
-0.23
10.42
OPM %
24.65%
-0.91%
25.02%
Other Income
0.11
0.3
0.63
Interest
0.91
1.04
0.76
Depreciation
0.07
0.05
0.08
PBT
7.48
-1.02
10.21
Tax %
25.53%
-23.53%
27.33%
Net Profit
5.57
-0.78
7.42
EPS (₹)
5.34
-0.55
5.24
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
22.89
12.44
19.47
32.78
46.11
61.58
66.96
Expenses
20.01
11.54
17.07
29.25
41.11
51.81
56.64
Operating Profit
2.88
0.9
2.4
3.53
5
9.77
10.32
OPM %
12.58%
7.23%
12.33%
10.77%
10.84%
15.87%
15.41%
Other Income
0.12
0.12
0.04
0.09
0.16
0.18
0.8
Interest
0.46
0.23
0.21
0.43
1.14
1.71
1.8
Depreciation
0.04
0.03
0.02
0.09
0.14
0.12
0.13
PBT
2.5
0.76
2.21
3.1
3.88
8.12
9.19
Tax %
26.8%
28.95%
26.24%
30.65%
26.29%
25.62%
27.86%
Net Profit
1.83
0.54
1.62
2.15
2.87
6.03
6.64
EPS (₹)
2.01
0.59
1.78
2.36
3.15
5.79
4.69
Div. Payout %
0%
0%
34.57%
24.42%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.1
0.1
0.7
0.7
0.7
10.42
14.17
Reserves
6.75
7.3
7.33
8.96
11.84
12.84
40.38
Borrowings
5.88
3.88
3.82
5.87
15.05
22.74
18.53
Other Liabilities
3.56
3.03
6.15
7.7
6.42
8.16
6.34
Total Liabilities
16.29
14.31
18
23.23
34.01
54.16
79.42
Fixed Assets
0.06
0.04
0.2
0.36
0.28
0.24
0.29
CWIP
0
0
0
0
0
0
0.4
Investments
0.47
0.11
0
0
0
0
0
Other Assets
15.76
14.16
17.8
22.87
33.73
53.92
78.73
Total Assets
16.29
14.31
18
23.23
34.01
54.16
79.42
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.38
4.31
0.48
-2.93
-8.04
-5.41
-8.36
Investing
0.1
0.37
-0.23
-0.32
-0.04
-0.05
0.05
Financing
0.28
-2
-0.81
1.17
8.19
10.71
18.8
Net Cash Flow
0
2.68
-0.55
-2.08
0.11
5.25
10.48
Free Cash Flow
-0.4
4.3
0.29
-3.19
-8.09
-5.49
-8.94
CFO/EBITDA
10
503
47
-54
-136
-35
-59
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
118
136
104
114
129
166
203
Inventory Days
234
366
282
274
247
202
256
Days Payable
28.2
98.96
65.19
61.56
31.74
48.84
24.33
Cash Conversion Cycle
324
403
321
326
344
320
434
Working Capital Days
189
238
105
102
93.96
96.79
199
ROCE %
—
8.25%
20.93%
25.79%
23.28%
26.72%
18.46%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aakaar Medical Technologies insights

61 extracted metrics + investor summaries across FY11–FY26.

Shareholding Pattern

Others5.92%Promot.67.05%DIIs10.13%Public16.90%As ofSep 2026

Documents

Frequently Asked Questions about Aakaar Medical Technologies

What does Aakaar Medical Technologies Ltd do?
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]
Where is Aakaar Medical Technologies Ltd (AAKAAR) listed?
Aakaar Medical Technologies Ltd trades as AAKAAR on the NSE.
Which sector does Aakaar Medical Technologies Ltd belong to?
Aakaar Medical Technologies Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Aakaar Medical Technologies Ltd?
Aakaar Medical Technologies Ltd has a market capitalisation of ₹99.14 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Aakaar Medical Technologies Ltd?
Over the last 52 weeks Aakaar Medical Technologies Ltd has traded between ₹46 and ₹89.95 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Aakaar Medical Technologies Ltd?
Aakaar Medical Technologies Ltd reported a return on equity of 12.17%. Its debt-to-equity ratio is 0.34.

Company Information

Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]

Website aakaarmedical.in
Listed 2025-06-27
Face Value ₹ 10
Shares Outstanding 1,41,72,816

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AAKAAR.md for Aakaar Medical Technologies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Personal Care stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month